News

Exciting news from the Global Pharma Health Fund! They’ve released a new low-cost Minilab test that detects toxic antifreeze agents like diethylene glycol and ethylene glycol in children’s cough syrups. This portable tool, especially crucial for regions lacking advanced labs, now includes protocols to safeguard against these harmful contaminants. Available for free in multiple languages, ...

The East African Community (EAC) has long faced challenges ensuring access to affordable, quality medicines. Since 2005, EAC Partner States have been working on an inter-country pooled procurement mechanism to address these issues, but progress has been slow. This study explores the evolution of this mechanism, highlighting two key stages: the initial promise stage, marked ...

We are delighted to announce that QUAMED has signed a contract with Relief International to run an exciting 4-year project: “Improving Access to Quality Medicines and Medical Supplies in Fragile and Conflict-Affected Countries”. The project will focus on building the capacity of 20 local medical product suppliers across Afghanistan, Yemen, Myanmar, and Syria. Following market ...

Excited to share a new analytical framework for evaluating access to medicines from a health systems perspective! Developed from a study on childhood oncology medicines in South Africa, this framework focuses on eight key pharmaceutical processes to identify barriers and facilitators to access. Targeting national processes guides effective policy development to improve healthcare outcomes. #HealthSystems ...

A recent study assessed access to mifepristone, misoprostol, and contraceptive medicines in eight Eastern Mediterranean countries, highlighting significant gaps. Despite their critical role in reducing maternal mortality, most countries did not include all WHO essential contraceptives in national guidelines. Only Lebanon and Pakistan had comprehensive family planning guidelines, and only Afghanistan and Lebanon included mifepristone ...

Sustainable access to affordable medicines is a global health issue, even for high-income countries. The fifth PPRI Conference, held in Vienna on 25-26 April 2024, will discuss innovative pharmaceutical policies to tackle current and future challenges. The event invites researchers, policymakers, payers, patients, industry representatives, and health professionals. Key topics include best practices and lessons ...

Join on May 21st from 12:45 PM to 2:00 PM GMT+2 for a discussion with Sadiq Samater, a Quality Control Consultant at the Somaliland Quality Control Commission. Sadiq, a UK pharmacist, will address the challenges of substandard and falsified medicines in Somaliland and the actions taken by SQCC. Don’t miss this opportunity to learn and ...